12:00 AM
 | 
Apr 22, 2013
 |  BC Week In Review  |  Company News  |  Deals

NanoString, Broad Institute of MIT and Harvard deal

NanoString said it received an exclusive option to license worldwide rights to a 186-gene gene signature for liver cancer from Broad Institute. NanoString said the signature...

Read the full 107 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >